Investment Spotlight: Doug Drysdale of Cybin (EP186)

Updated: Nov 12, 2021



Cybin CEO Doug Drysdale joins Jay Coulter and Chris Versace for this installment of the Investment Spotlight Series from Resilient Advisor.


About Cybin (from Cybin.com):

Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders.



Podcast


Sound Bites





Connect With Doug:


LinkedIn: https://www.linkedin.com/in/dougdrysdale


Twitter: https://twitter.com/insidepharma


Learn More About Cybin:


Website: https://www.cybin.com


LinkedIn: https://www.linkedin.com/company/cybin


Twitter: https://twitter.com/CybinInc


Facebook: https://www.facebook.com/cybinInc






7 views0 comments